Mundipharma International Holdings

Mundipharma is a global pharmaceutical organization that operates as a network of independent associated companies, primarily owned by the Sackler family. The company focuses on developing and commercializing medicines in core therapeutic areas such as pain management, oncology, respiratory diseases, and biosimilars. With a presence in over 120 countries, Mundipharma is recognized for its extensive portfolio of analgesics, including Targin and OxyContin, as well as its consumer health brand Betadine. The company also maintains a strong focus on specialty care and has established significant partnerships for the commercialization of innovative treatments like the antifungal rezafungin. Headquartered in Cambridge, UK, Mundipharma continues to expand its global footprint while navigating restructuring processes related to its ownership.